個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Cost Plus Drugs
內容大綱
In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more than 340 generic oral medications, selling their drugs at significantly lower prices than typical pharmacies. Oshmyansky could focus resources on adding brand-name drugs to its medication portfolio or focus on the company's ongoing development of a facility to manufacture sterile injectable drugs.